About Abhishek Bhuyan
Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.
Although Abhishek holds a bachelor's degree in science, his primary goal is to enhance his comprehension of self-learned investment research and provide valuable assistance to retail investors, enabling them to make informed investment decisions.
Recent Articles By Abhishek Bhuyan
3 Consumer Discretionary Stocks to Watch for Holiday Gains
The consumer discretionary sector is poised for significant growth, driven by changing consumer behaviors, rising incomes, and increasing demands for entertainment, apparel, and leisure, particularly during the holiday season. Therefore, investors could consider watching consumer discretionary stocks: Amazon.com (AMZN), The Home Depot (HD), and Target (TGT) for potential holiday gains. Keep reading...
3 Mid-Cap Stocks Analysts Predict Will Rally by Over 25%
Mid-cap stocks present a compelling investment opportunity due to their balanced risk, growth potential from expected interest rate cuts, strong earnings growth, which enhance long-term performance and diversification. Therefore, considering strong mid-cap stocks like Abercrombie & Fitch (ANF), PVH (PVH), and Semtech (SMTC), which are expected to soar by 25% or more, could be wise. Keep reading...
2 Video Game Stocks to Watch as the Metaverse Gains Momentum
As the metaverse gains momentum, investments in computing power and AI chips enhance gaming experiences, driving demand and making the video games market a compelling investment opportunity with significant growth potential. To that end, let’s analyze the fundamentals of two must-watch video game stocks: Tencent Holdings (TCEHY) and Electronic Arts (EA). Keep reading...
3 Dividend Stocks for Retirees Seeking Consistent Income
Dividend stocks provide reliable income streams, favorable tax rates, stability during economic downturns, and the potential for long-term portfolio growth. In this context, retirees may want to consider dividend-paying stocks like Coca-Cola (KO), Consolidated Edison (ED), and T. Rowe Price Group (TROW). Keep reading...
3 Latin American Stocks to Buy in 2024
The Latin American market is currently attractive due to its growth potential, diverse economies, and abundant resources. Therefore, it could be wise to consider buying top Latin American stocks: Petrobras (PBR), América Móvil (AMX), and Grupo Aeroportuario del Sureste (ASR) in 2024. Read more...
2 Gaming Stocks You Shouldn’t Miss in October
The gaming market is thriving due to the growth of mobile gaming, the rise of e-sports, AI integration, and AR/VR technologies, which are driving significant revenue and user engagement. To that end, let’s analyze the investment prospects of gaming stocks that one shouldn’t miss this October: Electronic Arts (EA) and Playtika Holding (PLTK). Keep reading...
3 Small-Cap Growth Stocks Wall Street Believes Will Soar
Small-cap growth stocks offer strong potential now due to robust economic growth, favorable sector performance, mispricing opportunities, and recent interest rate cuts, making Despegar.com (DESP), Fiverr International (FVRR), and FARO Technologies (FARO) attractive for diversification and higher returns, with Wall Street believing these stocks will soar. Read more...
3 AI ETFs to Watch as Technology Transformations Speed Up
Investing in AI ETFs is a smart move now, driven by rapid AI adoption, strong market demand, and the diversification that reduces risk while capturing growth potential. Amid this backdrop, tech investors should consider keeping an eye on robust AI ETFs, such as Global X Robotics & Artificial Intelligence (BOTZ), ARK Autonomous Technology & Robotics (ARKQ), and Robo Global Artificial Intelligence (THNQ). Read on...
3 Pharmaceutical Stocks That Could Lead the Next Drug Revolution
The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst economic shifts, rising chronic illnesses, and strong growth projections in global revenues and biotechnology markets. Therefore, it could be wise to invest in pharma stocks such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Gilead Sciences (GILD), which could lead the next drug revolution. Read more...